GGrantIndex
Sort

17,288 grants matching multiple sclerosis

Human Brain Vascular Phenotyping with High-Field MRI:Water Permeability Mapping

$305,613
William D Rooney · Oregon Health & Science University · R01 · FY2008 · EB

Human Brain Vascular Phenotyping with High-Field MRI:Water Permeability Mapping

$305,613
William D Rooney · Oregon Health & Science University · R01 · FY2009 · EB

SIGNALING BY NEUREGULINS AND ERBB4 IN BREAST CANCER

$305,511
Yale University · R01 · FY2001 · CA

Fidelity of Repair within Repetitive DNA

$305,505
Catherine H Freudenreich · Brandeis University · P01 · FY2015 · GM

Mechanisms of CD4+CD25+ T Regulatory Cells in EAE

$305,492
Stephen D Miller · Northwestern University At Chicago · R01 · FY2008 · NS

The Effect of Vaporized Cannabis on Neuropathic Pain in Spinal Cord Injury

$305,474
Barth Lance Wilsey · University Of California At Davis · R01 · FY2012 · DA

Crosstalk between Brassinosteroid and autophagy pathways in the regulation of plant growth and stress responses

$305,438
Yanhai Yin · Iowa State University · R01 · FY2018 · GM

B cells alter adaptive autoimmunity to protect from ischemic injury after stroke

$305,385
Ann Marie Stowe · Ut Southwestern Medical Center · R01 · FY2018 · NS

Cytokine regulation of glial reactivity

$305,363
Gareth R John · Icahn School Of Medicine At Mount Sinai · R01 · FY2007 · NS

Spatial Regulation of Cytoskeleton During Chemotaxis

$305,351
Chang Y Chung · Vanderbilt University · R01 · FY2012 · GM

Spatial Regulation of Cytoskeleton During Chemotaxis

$305,351
Chang Y Chung · Vanderbilt University · R01 · FY2011 · GM

Mouse Brain Models of Tuberous Sclerosis

$305,345
David J. Kwiatkowski · Massachusetts General Hospital · P01 · FY2010 · NS

Mouse Brain Models of Tuberous Sclerosis

$305,344
David J. Kwiatkowski · Massachusetts General Hospital · P01 · FY2011 · NS

Efficacy and Safety of Galantamine for Dysfunction in Bipolar Disorder

$305,344
Dan Vlad Iosifescu · Icahn School Of Medicine At Mount Sinai · R01 · FY2011 · MH

Development of Novel p38 MAPK Inhibitors as Therapeutics for CNS Disorders

$305,334
D. Martin Watterson · Northwestern University At Chicago · R01 · FY2010 · AG

Actomyosin motors and Mechanism of Myelin Formation

$305,304
Carmen V Melendez-Vasquez · New York University School Of Medicine · R01 · FY2006 · NS

Molecular mechanisms of gasdermins and pyroptosis

$305,267
Tsan Sam Xiao · Case Western Reserve University · R01 · FY2020 · GM

Regulation of the Unfolded Protein Response by eIF2 alpha phosphatases

$305,216
Douglas Conrad Weiser · University Of The Pacific-Stockton · R15 · FY2017 · GM

NSCs produce a triply effective cocktail in the CNS for MS/EAE therapy

$305,156
Guang-Xian Zhang · Thomas Jefferson University · R01 · FY2012 · NS

NSCs produce a triply effective cocktail in the CNS for MS/EAE therapy

$305,156
Guang-Xian Zhang · Thomas Jefferson University · R01 · FY2015 · NS

NSCs produce a triply effective cocktail in the CNS for MS/EAE therapy

$305,156
Guang-Xian Zhang · Thomas Jefferson University · R01 · FY2016 · NS

Treatment of Demyelinating Disease with HSP90 Inhibitors

$305,156
Douglas L Feinstein · University Of Illinois At Chicago · R01 · FY2009 · NS

Treatment of Demyelinating Disease with HSP90 Inhibitors

$305,156
Douglas L Feinstein · University Of Illinois At Chicago · R01 · FY2008 · NS

NK cell responses to JC polyomavirus

$305,151
Chen Sabrina Tan · University Of Iowa · R01 · FY2023 · NS

Cytokines in Glial Cells and EAE Brain

$305,136
Inderjit Singh · Medical University Of South Carolina · R01 · FY2013 · NS